Absorbable dressing paste for wound surface
By integrating the hydrophobic layer, hydrophilic layer, bactericidal layer and decellularized dermal matrix layer in the dressing patch, the shortcomings of existing dressings in absorbing ooze and promoting repair are solved, and the effect of preventing the outflow of water vapor and medicine liquid is achieved, and the effect of promoting the promotion of Skin heals and reduces the risk of infection.
Patent Information
- Application Number
- CN202420892675.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2024-04-27
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2034-04-27
AI Technical Summary
Existing dressings have their own advantages and disadvantages in promoting wound healing. Hydrophilic dressings absorb leucorrhea but do not promote repair. Decellularized dermal matrix dressings promote repair but have poor ability to absorb leucorrhea, which can easily lead to infection risk and are prone to adhesion to wounds. Causes mechanical damage.
A wound-absorbable dressing patch is designed, including a hydrophobic layer, a hydrophilic layer, a bactericidal layer, a decellularized dermal matrix layer and a nonwoven layer. The hydrophobic layer is located at the outermost layer to prevent water vapor from entering, and the hydrophilic layer locks the drug liquid. The decellularized dermal matrix layer promotes cell growth, the bactericidal layer prevents infection, and uses the non-woven layer to absorb sweat and breathe.
It achieves preventing the entry of external water vapor and drug fluid from flowing out without affecting wound healing, promoting cell growth, reducing the risk of infection, and improving the effect of wound healing.
Smart Images

Figure CN222075417U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to the technical field of dressing patches, in particular to an absorbable wound dressing patch. Background Art
[0002] Common skin wounds in clinical practice include acute wounds and chronic wounds. Wound healing is a complex process involving multiple cell types involved in the reconstruction of functional tissues. Normal wound healing is divided into four stages: hemostasis, inflammation, proliferation, and remodeling. When the wound area of an acute wound is small, it can generally be healed through the normal wound healing process. Severe acute wounds are also difficult to heal in a short period of time through the body's self-healing ability. Chronic wounds (also known as refractory wounds) caused by potential conditions such as persistent trauma, infection or ischemia, vascular disease, and diabetes are difficult to heal due to the lack of effective inflammatory response and the lack of available extracellular matrix. With the in-depth study of the pathophysiology of the wound healing process, people have a deeper understanding of the wound healing process, which has led to the continuous improvement and development of wound dressings. In the field of wound care, there are a large number of dressing products on the market. Such products are used in large quantities, are low-priced, and have a wide variety. Different types of dressings are used for different wound stages.
[0003] Common dressings include hydrophilic dressings with sodium carboxymethylcellulose hydrocolloid as the main component, absorbent dressings with polymer foam or alginate as the main component, dressings containing silver ions with sterilization function, polymer film dressings that are two-in-one dressings and tapes, and acellular dermal matrix dressings that can promote wound repair. Hydrophilic and exudate-absorbing dressings only have the function of absorbing exudate and maintaining a moist environment on the wound surface. They do not have the function of promoting wound repair, and are prone to adhesion to the granulation tissue on the wound surface. When changing the dressing, it is easy to cause mechanical damage to the wound surface and increase the patient's pain. Acellular dermal matrix biological dressings have the function of promoting cell crawling and providing ECM scaffolds for tissue growth, but they have poor exudate absorption and poor air permeability. For wounds with more exudate, it is easy to cause exudate accumulation under the dressing, increasing the risk of infection. Therefore, the current dressings have their own advantages and disadvantages. Utility Model Content
[0004] In view of the problems existing in the existing absorbable wound dressing, the utility model is proposed.
[0005] In order to solve the above technical problems, according to one aspect of the present invention, the present invention provides the following technical solutions:
[0006] A wound absorbable dressing comprises a postoperative dressing layer, a non-woven fabric layer is arranged above the postoperative dressing layer, an acellular dermal matrix layer is arranged above the non-woven fabric layer, a bactericidal layer is arranged above the acellular dermal matrix layer, a hydrophilic layer is arranged above the bactericidal layer, and a hydrophobic layer is arranged above the hydrophilic layer.
[0007] As a preferred embodiment of the absorbable wound dressing patch described in the utility model, the non-woven fabric layer is set as a non-woven fabric material, the acellular dermal matrix layer is set as an acellular dermal matrix dressing, and the bactericidal layer is set as a dressing with silver ions.
[0008] As a preferred solution of the absorbable wound dressing patch described in the utility model, the hydrophilic layer is set as a hydrophilic dressing, and the hydrophobic layer is set as a hydrophobic dressing.
[0009] As a preferred embodiment of the absorbable wound dressing patch described in the utility model, the hydrophilic material used in the hydrophilic layer is polyvinyl alcohol, collagen, gelatin, chitosan, starch or agar, and the hydrophobic material used in the hydrophobic layer is set to polylactic acid, polyglycolide, polycaprolactone, polyvinyl alcohol, polyethylene terephthalate, polytetrafluoroethylene, polyvinylidene fluoride, polyurethane, polyester amide, polymethyl methacrylate, polyhydroxybutyrate, polyethylene oxide, polyurethane and its derivatives or polycarbonate.
[0010] As a preferred embodiment of the absorbable wound dressing patch described in the utility model, the hydrophobic layer and the hydrophilic layer are bonded by a first adhesive, the hydrophilic layer and the bactericidal layer are bonded by a second adhesive, the bactericidal layer and the decellularized dermal matrix layer are bonded by a third adhesive, the decellularized dermal matrix layer and the non-woven fabric layer are bonded by a fourth adhesive, and the non-woven fabric layer and the postoperative dressing patch layer are bonded by a fifth adhesive.
[0011] Compared with existing technologies:
[0012] By integrating the advantages and disadvantages of various existing dressings, a hydrophobic layer, a hydrophilic layer, a bactericidal layer, an acellular dermal matrix layer, a non-woven fabric layer, and a postoperative dressing layer are provided. The postoperative dressing layer is adhered to the skin, and the acellular dermal matrix layer is used to promote cell crawling and provide an ECM scaffold for tissue growth. The hydrophobic layer is located at the outermost layer, thereby preventing external water vapor from entering the dressing and then contacting the wound to affect wound healing, and also preventing the liquid medicine in the hydrophilic layer from flowing out. BRIEF DESCRIPTION OF THE DRAWINGS
[0013] Figure 1 A schematic diagram of the structure provided for Example 1 of the utility model;
[0014] Figure 2 This is a schematic diagram of the structure provided for Example 2 of the utility model.
[0015] In the figure: hydrophobic layer 1, hydrophilic layer 2, bactericidal layer 3, acellular dermal matrix layer 4, non-woven fabric layer 5, postoperative dressing layer 6, first adhesive 12, second adhesive 23, third adhesive 34, fourth adhesive 45, fifth adhesive 56. DETAILED DESCRIPTION
[0016] In order to make the purpose, technical solution and advantages of the present invention more clear, the implementation mode of the present invention will be further described in detail below with reference to the accompanying drawings.
[0017] Embodiment 1:
[0018] The utility model provides a wound absorbable dressing patch, please refer to Figure 1 , including a postoperative dressing layer 6, a non-woven fabric layer 5 is provided above the postoperative dressing layer 6, a decellularized dermal matrix layer 4 is provided above the non-woven fabric layer 5, a bactericidal layer 3 is provided above the decellularized dermal matrix layer 4, a hydrophilic layer 2 is provided above the bactericidal layer 3, and a hydrophobic layer 1 is provided above the hydrophilic layer 2; the postoperative dressing layer 6 contacts the wound and will not adhere to the wound; the decellularized dermal matrix layer 4 has the function of promoting cell crawling and providing an ECM scaffold for tissue growth; the non-woven fabric layer 5 is used to absorb sweat and allow air to pass through; a plurality of pores are provided in the decellularized dermal matrix layer 4 for ventilation.
[0019] The non-woven fabric layer 5 is set as a non-woven fabric material, the acellular dermal matrix layer 4 is set as an acellular dermal matrix dressing, and the sterilization layer 3 is set as a dressing with silver ions. The dressing with silver ions is used to achieve the sterilization purpose and prevent the wound from being infected.
[0020] The hydrophilic layer 2 is set as a hydrophilic dressing patch, and the hydrophobic layer 1 is set as a hydrophobic dressing patch. The hydrophobic layer 1 can prevent external water vapor from entering. When the dressing patch is used, the postoperative dressing patch 6 is in contact with the wound, and the hydrophobic layer 1 is located at the outermost layer, thereby preventing external water vapor from entering the dressing patch and then contacting the wound to affect wound healing, and also preventing the liquid medicine in the hydrophilic layer 2 from flowing out.
[0021] The hydrophilic material used in the hydrophilic layer 2 is polyvinyl alcohol, collagen, gelatin, chitosan, starch or agar, and the hydrophobic material used in the hydrophobic layer 1 is set to polylactic acid, polyglycolide, polycaprolactone, polyvinyl alcohol, polyethylene terephthalate, polytetrafluoroethylene, polyvinylidene fluoride, polyurethane, polyesteramide, polymethyl methacrylate, polyhydroxybutyrate, polyethylene oxide, polyurethane and its derivatives or polycarbonate; the hydrophilic layer 2 can lock the liquid medicine in the dressing well, thereby achieving the purpose of wound treatment.
[0022] Embodiment 2:
[0023] Refer to the attached Figure 2 , which is different from Example 1, is that: the hydrophobic layer 1 and the hydrophilic layer 2 are bonded by a first adhesive 12, the hydrophilic layer 2 and the bactericidal layer 3 are bonded by a second adhesive 23, the bactericidal layer 3 and the acellular dermal matrix layer 4 are bonded by a third adhesive 34, the acellular dermal matrix layer 4 and the non-woven fabric layer 5 are bonded by a fourth adhesive 45, and the non-woven fabric layer 5 and the postoperative dressing layer 6 are bonded by a fifth adhesive 56. The first adhesive 12, the second adhesive 23, the third adhesive 34, the fourth adhesive 45, and the fifth adhesive 56 are all configured as double-sided adhesives and are all ring-shaped, so that while the layers are connected, a cavity is formed between the layers, and the cavity is used to achieve breathable heat dissipation.
[0024] Although the present invention has been described above with reference to the embodiments, various modifications may be made thereto and parts thereof may be replaced with equivalents without departing from the scope of the present invention. In particular, as long as there is no structural conflict, the various features in the embodiments disclosed in the present invention may be used in combination with each other in any manner, and the fact that these combinations are not exhaustively described in this specification is only for the sake of omitting space and saving resources. Therefore, the present invention is not limited to the specific embodiments disclosed herein, but includes all technical solutions falling within the scope of the claims.
Claims
1. An absorbable wound dressing, comprising a postoperative dressing layer (6), characterized in that: A non-woven fabric layer (5) is provided above the postoperative dressing layer (6), an acellular dermal matrix layer (4) is provided above the non-woven fabric layer (5), a bactericidal layer (3) is provided above the acellular dermal matrix layer (4), a hydrophilic layer (2) is provided above the bactericidal layer (3), and a hydrophobic layer (1) is provided above the hydrophilic layer (2).
2. The absorbable wound dressing according to claim 1, characterized in that: The non-woven fabric layer (5) is configured as a non-woven fabric material, the acellular dermal matrix layer (4) is configured as an acellular dermal matrix dressing, and the bactericidal layer (3) is configured as a dressing containing silver ions.
3. The absorbable wound dressing according to claim 1, characterized in that: The hydrophilic layer (2) is configured as a hydrophilic dressing, and the hydrophobic layer (1) is configured as a hydrophobic dressing.
4. The absorbable wound dressing according to claim 3, characterized in that: The hydrophilic material used in the hydrophilic layer (2) is polyvinyl alcohol, collagen, gelatin, chitosan, starch or agar, and the hydrophobic material used in the hydrophobic layer (1) is set to polylactic acid, polyglycolide, polycaprolactone, polyvinyl alcohol, polyethylene terephthalate, polytetrafluoroethylene, polyvinylidene fluoride, polyurethane, polyester amide, polymethyl methacrylate, polyhydroxybutyrate, polyethylene oxide, polyurethane and its derivatives or polycarbonate.
5. The absorbable wound dressing according to any one of claims 1 to 4, characterized in that: The hydrophobic layer (1) and the hydrophilic layer (2) are bonded by a first adhesive (12), the hydrophilic layer (2) and the bactericidal layer (3) are bonded by a second adhesive (23), the bactericidal layer (3) and the acellular dermal matrix layer (4) are bonded by a third adhesive (34), the acellular dermal matrix layer (4) and the non-woven fabric layer (5) are bonded by a fourth adhesive (45), and the non-woven fabric layer (5) and the postoperative dressing layer (6) are bonded by a fifth adhesive (56).
